Post-market Reviews of Chronic Obstructive Pulmonary Disease (COPD) medicines and Ezetimibe – Public Consultation

Page last updated: 4 March 2016

The public submission process is now open for the Post-market Reviews of:

1. Chronic Obstructive Pulmonary Disease medicines; and
2. Ezetimibe.

Interested organisations and individuals are invited to provide a submission addressing the Reviews’ Terms of Reference.  To make a submission please go to the relevant Public Consultation page:

1. for COPD Medicines, or
2. for Ezetimibe.

The public submission process will be open for 7 weeks and will close at 5pm Friday, 22 April 2016.      

Further information on the Reviews are available on the COPD Review website or the Ezetimibe Review website.